Skip to main content

Why Biotech Sponsors Need Outside Support: IRB, IBC, DMCs and EACs

Emerging biotech companies must navigate the complexities of development and approval – often with no previous experience. Speed, quality, predictability, and risk management are a few of the many reasons biotech sponsors need one partner for all study reviews.

Download our whitepaper to:

  • Determine the need for an IBC.
  • Assess prospective site lists.
  • Ascertain the need for EACs and DMCs.
  • Understand independent reviews.
  • Discover how one partner for IRB, IBC, EAC, DMC saves resources.

Download Your Free Copy Today